Solid Biosciences's total assets for Q3 2025 were $273.91M, a decrease of -11.15% from the previous quarter. SLDB total liabilities were $55.97M for the fiscal quarter, a 11.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.